Latest / SAGA — Success Stories | AGORA Intelligence

Takeda: How AI Reshaped Drug Discovery R&D
The MIT Sloan Management Review case of 1 October 2026 tells the story of Takeda Pharmaceutical: AI inside the research and development workflows, scientists moved from broad experimentation to data-driven prediction with targeted validation, and four conditions (three of them organisational) underpinning scale. The mandate from then-chief executive Christophe Weber called for rethinking 80% of processes by 2028. The before/after figures on discovery productivity stay outside the published text.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.